We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VBS market cap is 14.63M. The company's latest EPS is AUD -0.0648 and P/E is -4.17.
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 9k | 50k | 1.02M | 1.3M | 1.3M |
| Operating Income | -2.37M | -2.67M | -2.79M | -3.3M | -3.3M |
| Net Income | -1.6M | -3M | -3.86M | -3.99M | -3.45M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 194k | 3M | 6.98M | 3.94M | 4.63M |
| Total Liabilities | 3.92M | 8.64M | 8.87M | 7.47M | 1.11M |
| Total Equity | -3.73M | -5.65M | -1.89M | -3.53M | 3.52M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -1.04M | -3M | -3.26M | -4.44M | -2.35M |
| Investing | N/A | N/A | N/A | -21k | -17k |
| Financing | 1.04M | 5.64M | 6.35M | -35k | 4.04M |
| Market Cap | 14.63M |
| Price to Earnings Ratio | -4.17 |
| Price to Sales Ratio | 11.07 |
| Price to Cash Ratio | 4.86 |
| Price to Book Ratio | 4.08 |
| Dividend Yield | - |
| Shares Outstanding | 53.21M |
| Average Volume (1 week) | 13.03k |
| Average Volume (1 Month) | 19.22k |
| 52 Week Change | -46.60% |
| 52 Week High | 0.55 |
| 52 Week Low | 0.20 |
| Spread (Intraday) | 0.15 (55.56%) |
| Company Name | Vectus Biosystems Limited |
| Address |
3-11 primrose avenue sydney, new south wales 2018 |
| Website | https://www.vectusbiosystems.com.au |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
